GRACE :: Lung Cancer

Dr. Greg Riely: How I Use Molecular Marker Information in Earlier Stage NSCLC Patients

Share
download as a pdf file Download PDF

Dr. Greg Riely from Memorial Sloan-Kettering notes how he feels molecular marker results for patients with earlier stage lung cancer can potentially be valuable.


Leave a Reply

Ask Us, Q&A
Lung/Thoracic Cancer Expert Content

Archives

Breast Cancer Blog
Pancreatic Cancer Blog
Kidney Cancer Blog
Bladder Cancer Blog
Head/Neck Cancer Blog

Recent Lung Blog Comments

Other Resources